Background Normalization of hypercortisolism is essential to reduce morbidity and mortality
in patients with Cushing's syndrome (CS). The aim of this analysis was to assess …

It is held that the condition of endogenous chronic hypersecretion of cortisol (Cushing
syndrome, CS), causes several comorbidities, including cardiovascular and metabolic …

Prompt control of hypercortisolism is needed to reverse clinical and biochemical
manifestations and decrease excess morbidity and mortality in patients with endogenous …

Purpose Cushing's syndrome is a rare but frequently considered disease. Its diagnosis can
lead to some difficulties, including confirming the effective endogenous hypercortisolism and …

Transsphenoidal surgery is the first‐line treatment of Cushing's disease. However, medical
treatment can be given in a high proportion of patients with this rare condition. This is …

Pituitary surgery is the first-line treatment for patients with Cushing's disease. For patients
who are not considered candidates for pituitary surgery, pituitary radiation and bilateral …

Objective: Cushing disease (CD) results from excessive exposure to glucocorticoids caused
by an adrenocorticotropic hormone–secreting pituitary tumor. Inadequately treated CD is …

Cushing syndrome (CS) caused by endogenous hypercortisolism is a diagnostic challenge.
The most common cause is Cushing disease. Surgical treatment is the first-line therapy for …

Endogenous hypercortisolism is characteristically a condition that should be diagnosed and
treated in tertiary care centers with the participation of several specialists. Cushing's …

Cushing's syndrome (CS) is associated with serious comorbidities and an increased
mortality rate that could be reduced only if strict biochemical control is achieved. The aim of …